Advancements in the Growth and Construction of Recombinant Lumpy Skin Disease Virus (LSDV) for Use as a Vaccine Vector

Advancements in the Growth and Construction of Recombinant Lumpy Skin Disease Virus (LSDV) for Use as a Vaccine Vector

Attenuated vaccine strains of lumpy skin disease virus (LSDV) have become increasingly popular as recombinant vaccine vectors, to target both LSDV, as well as other pathogens, including human infectious agents. Historically, these vaccine strains and recombinants were generated in primary (lamb) tes...

Full description

Bibliographic Details
Main Authors: Michiel van Diepen, Rosamund Chapman, Nicola Douglass, Leah Whittle, Nicole Chineka, Shireen Galant, Christian Cotchobos, Akiko Suzuki, Anna-Lise Williamson
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Vaccines
Subjects:
lumpy skin disease virus
vaccine vector
BHK-21 cells
RK13 cells
K1L host range
Online Access:https://www.mdpi.com/2076-393X/9/10/1131

Similar Items

Similar Items